Free Trial
Sam Slutsky

Sam Slutsky Analyst Performance

Sr. Research Analyst at Lifesci Capital

Sam Slutsky is a stock analyst at Lifesci Capital in the medical sector, covering 2 publicly traded companies. Over the past year, Sam Slutsky has issued 2 stock ratings, including and buy recommendations. While full access to Sam Slutsky's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Sam Slutsky's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
2 Last 0 Years
Buy Recommendations
100.00% 2 Buy Ratings
Companies Covered
2 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%2 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
2 companies

Sam Slutsky, an analyst at Lifesci Capital, currently covers 2 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
2 companies
100.0%

Sam Slutsky of Lifesci Capital specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
2 companies
100.0%

About Sam Slutsky

Sam Slutsky is a Senior Research Analyst at LifeSci Capital, having joined the firm in 2015. His coverage universe includes a diverse range of therapeutic areas, including oncology and immunology. Prior to LifeSci, Sam conducted orthopedic research under Dr. Javad Parvizi at the Rothman Institute in Philadelphia. His work was presented at the American Association of Hip and Knee Surgeons (AAHKS) 24th annual meeting. Sam holds a Bachelor of Arts in Economics from the University of Rochester and also completed the pre-med track. He was a member of the school’s NCAA baseball team, where he compiled several accolades including all-conference and academic all-district.
Follow on LinkedIn

Sam Slutsky's Ratings History at Lifesci Capital

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
8/4/2025Initiated Coverage$36.55$90.00Outperform
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
7/23/2025Boost Price Target$67.67$101.00Outperform